WeVote

Bill

Bill

PR 26-0687

Board of Pharmacy Dr. Allison Hill Confirmation Resolution of 2026

26th Council Period (2025-2026) Introduced by Phil Mendelson

Confirms Dr. Allison Hill’s reappointment to the DC Board of Pharmacy, ensuring continued governance, oversight, and public safety in pharmacist practice through March 12, 2028.

Resolution R26-0426, Effective from Jun 30, 2026 Published in DC Register Vol 73 and Page 009429
0
WeVote Research Nonpartisan
Bill Summary · PR 26-0687

Summary of Bill PR 26-0687 | Board of Pharmacy Dr. Allison Hill Confirmation Resolution of 2026

Purpose and Intent

  • The bill requests the Council of the District of Columbia to confirm the appointment (reappointment) of Dr. Allison Hill as a pharmacist licensed in the District to serve as a member of the Board of Pharmacy.
  • The term of appointment would end March 12, 2028.

Key Provisions

  • Sec. 2: Confirms the reappointment of Dr. Allison Hill, located in Ward 7 (Anacostia Avenue, NE, Washington, DC 20019), as a pharmacist licensed in the District member of the Board of Pharmacy, pursuant to the District of Columbia Health Occupations Revision Act of 1985.
  • Sec. 3: Requires transmission of the adopted resolution to the nominee and the Mayor’s Office.
  • Sec. 4: States that the resolution takes effect immediately upon adoption.
  • The resolution designates the formal title: “Board of Pharmacy Dr. Allison Hill Confirmation Resolution of 2026.”

Nominee Background (as presented in the bill materials)

  • Dr. Allison Hill, PharmD, RPh, a licensed pharmacist and current CVS Health pharmacist with experience as a pharmacy manager and preceptor.
  • Education: Doctor of Pharmacy from Howard University; BA in Chemistry from North Carolina State University.
  • Professional experience highlights include management responsibilities, patient communication, supervision and training of staff, and collaboration with federal, state, and local health initiatives.
  • Community involvement and leadership roles with various organizations (The Links, Incorporated; NSBE Jr; Junior League of Washington; Epidemic Rx; Miss Earth USA state director roles in the past) and volunteer activities.
  • Location and residency: Ward 7 resident in Washington, DC.

Affected Parties

  • Primary: Dr. Allison Hill as a sitting member of the DC Board of Pharmacy.
  • The Board of Pharmacy (DC Regulatory Body for pharmacists) would continue to comprise licensed pharmacists overseeing regulatory and disciplinary functions, ensuring safe practice and professional standards.
  • General public and DC health-care community, which rely on board governance for licensure administration, disciplinary actions, and pharmacy practice standards.

Procedural and Timeline Details

  • Legal sufficiency review conducted by the Mayor’s Office (Office of the General Counsel) indicating no legal objections to the nomination.
  • Action history:
    • Introduced: May 4, 2026.
    • Referred to Committee on Health: May 19, 2026.
  • Upon adoption, the resolution would be transmitted to the nominee and to the Mayor’s Office and would take effect immediately.

Key Dates to Note

  • Nomination date: May 4, 2026.
  • Confirmation term end date: March 12, 2028.
  • Proposed immediate effectiveness upon adoption.

Overall Impact

  • The bill facilitates the formal confirmation and ongoing service of Dr. Allison Hill on the District of Columbia Board of Pharmacy.
  • It ensures continued governance and oversight of pharmacy practice in the District, supporting regulatory consistency, public safety, and professional standards for pharmacists within the licensed community.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.